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Available online xxxxConcerns on the presence of emerging contaminants (ECs) in water sources have increased in recent years. The
lack of efﬁcient technologies to remove ECs from residual waters contributes for their appearance in drinking
water distribution systems (DWDS). Therefore, sessilemicroorganisms onDWDSpipes are continuously exposed
to trace concentrations of ECs. However, no data exists on the role of ECs on the resident microbiota. The present
work aims to understand the effects of prolonged exposure of a bacterial strain of Stenotrophomonas maltophilia,
isolated from a DWDS, in both planktonic and bioﬁlm states, to trace concentrations of selected ECs (antipyrine–
ANTP; diclofenac sodium salt–DCF; ibuprofen–IBP; galaxolide–GAL; tonalide–TON; carbamazepine–CBZ;
cloﬁbric acid–CA; tylosin–TY) on its tolerance to sodium hypochlorite (NaOCl) and resistance to antibiotics.
Pre-established S. maltophilia bioﬁlms were exposed to ECs for 26 d. Subsequently, the planktonic behaviour of
the bioﬁlm cells grown in the presence of ECS was characterized in terms of susceptibility to NaOCl and to se-
lected antibiotics (levoﬂoxacin and trimethoprim-sulfamethoxazole). Moreover, S. maltophiliawas tested on its
bioﬁlm productivity in the presence of ECs (alone and mixed). These bioﬁlms were challenged by NaOCl in
order to assess the role of ECs on bioﬁlm susceptibility. The results did not evidence remarkable effects of ECs
on planktonic S. maltophilia susceptibility to NaOCl and antibiotics. However, S. maltophilia bioﬁlm production
and susceptibility to NaOCl was affected from ECs pre-exposure, particularly by the combination of different
ECs (CA + CBZ, CA + IBP, CA + CBZ + IBP). S. maltophilia bioﬁlms became more resistant to removal by
NaOCl when developed in the presence of mixtures of CA + CBZ and CA + CBZ + IBP. Also, bioﬁlm production
was signiﬁcantly affected. CA was present in all the combinations that altered bioﬁlm behaviour. The overall re-
sults propose that exposure to ECs for 26 days had not a huge impact on S. maltophilia planktonic antimicrobialKeywords:
Bioﬁlm control
Chlorine
Drinking water disinfection
Emerging contaminants
Stenotrophomonas maltophilia
1349I.B. Gomes et al. / Science of the Total Environment 643 (2018) 1348–1356susceptibility. Nevertheless, the prolonged exposure to some ECs altered bioﬁlm production and tolerance to
NaOCl, with a potential practical outcome of hindering DWDS disinfection. The simultaneous presence of differ-
ent ECs in the environment may amplify bioﬁlm resilience.
© 2018 Elsevier B.V. All rights reserved.1. Introduction
Emerging contaminants (ECs), also deﬁned asmicropollutants, are a
vast and expanding array of anthropogenic and natural substances that
have been recently found in the environment. These ECs are continu-
ously released into the environment and have been found in surface
water, wastewater, groundwater and drinking water (DW), at very
low concentrations (from ng/L to μg/L) (Petrie et al., 2015; Richardson
and Kimura, 2017). ECs include pharmaceuticals and personal care
products (PPCPs), steroid hormones, industrial chemicals, pesticides
and many other emerging substances (Luo et al., 2014). Current waste-
water treatment plants (WWTPs) are unable to completely remove ECs.
Therefore, these compounds arrive to water typically from wastewater
treatment plants that treat domestic sewage, wastewater from hospital
efﬂuents and chemical manufacturing plants, as well as from livestock
and agriculture (Cunningham et al., 2009; Pal et al., 2010; Zhang et al.,
2014). Water efﬂuents are discharged into rivers and watercourses,
while sludge is spread on the soil as fertilizers, enabling ECs to reach
all the environmentalwater sources (Vulliet and Cren-Olive, 2011). Fur-
thermore, some ECs are environmentally persistent, bioactive and have
the potential for bioaccumulation (de Solla et al., 2016; Sui et al., 2015).
The worldwide detection of ECs in DW took the attention of the World
Health Organization (WHO), who published a report exclusively about
the presence of pharmaceuticals in DW and the potential risks for
human health and for the environment (WHO, 2011). Regardless the
limited knowledge on the ECs toxicity to human health, DW is a major
focus of consumers concern as it is a direct route for ECs to the human
body (Jones et al., 2005). In fact, the presence of ECs in the aquatic envi-
ronment has been frequently associated to diverse problems: toxicity,
endocrine disrupting effects and antibiotic resistance of microorgan-
isms. For example, pharmaceutical compounds which are specially de-
signed to produce biological response in a target organism may also
produce this response in non-target organisms when chronically ex-
posed to trace concentrations of these compounds (Wilkinson et al.,
2016). Some ECs, namely endocrine disrupting chemicals, are known
to affect the endocrine function of non-target organisms disrupting
the estrogenic hormonal pathways (Fisher and Eugster, 2014; Sarria
et al., 2011; Vajda et al., 2011). Some anti-inﬂammatory drugs, such as
diclofenac and naproxen, can cause impairment of health of non-
target organisms found in stream bioﬁlms (Corcoll et al., 2014).
Schwaiger et al. (2004) found that the extended exposure to trace levels
of diclofenac caused alterations in rainbow trout kidney and gills.
Naproxen at sublethal concentrations was responsible for oxidative
stress and genotoxicity in Hyalella azteca, an amphipod crustacean
(Lucero et al., 2015). Some other ECs as plasticizers or musk fragrances
were detected in human tissues and ﬂuids. Galaxolide and tonalide are
two polycyclic musk fragrances whose ecological and human toxicity is
still unknown. Nevertheless, these compounds have been detected in
human blood, adipose tissue and breast milk (Wombacher and
Hornbuckle, 2009). Duedahl-Olesen et al. (2005) also found galaxolide
in trout samples. A possible estrogenic activity of musk fragrances was
described by Bitsch et al. (2002), who observed an increase in the pro-
liferation rate of humanMCF-7 breast cancer cells relatedwith the pres-
ence of two nitro musks (musk xylene, musk ketone), p-amino musk
xylene (amajor metabolite of musk xylene) and tonalide. The exposure
to ECs is also known to be responsible for changes in the composition
and behavior of microbial communities. Of particular concern is the de-
velopment of resistance to antibiotics and the spread of antibiotic resis-
tant bacteria (ARB) and genes (ARG),which can be a consequence of theprolonged presence of antibiotics in aquatic environments (Baquero
et al., 2008; Berglund, 2015; Martinez, 2009). However, not only antibi-
otics may be responsible for bacterial resistance to antibiotics. Several
works demonstrated that water pollution with ECs, including non-
antibiotic drugs, has an important role on the acquisition and spread
of bacterial resistance determinants (Corcoll et al., 2014; Subirats
et al., 2017, 2018). As most of ECs are used worldwide and are essential
formodern society (Gavrilescu et al., 2015) it is of utmost importance to
better understand their possible effects on the exposed microbiota.
Despite the multiple disinfection processes used in drinking water
distribution systems (DWDS) to keep the DW microbiologically safe
for consumers, bioﬁlm development in pipe walls and other ﬁttings is
unavoidable (Simões and Simões, 2013). The presence of bioﬁlms con-
stitutes a global concern for DW companies. In fact, bioﬁlms can act as
reservoir for pathogenic microorganisms that, if released to the bulk
water, may be a source of waterborne diseases (Simões and Simões,
2013). Microorganisms in bioﬁlms are protected from environmental
stresses due to the production of an extracellular polymeric matrix
that hinders the penetration of disinfectants and other antimicrobials.
The sophisticated bioﬁlm structure causes the failure of conventional
DW disinfection strategies in effective bioﬁlm control (Gomes et al.,
2016, 2018).
The aim of the presentworkwas to understand the role of prolonged
exposure to selected ECs on bioﬁlm formation and antimicrobial toler-
ance of a Stenotrophomonas maltophilia strain isolated from DW.
S. maltophilia is an emerging opportunistic bacterium characterized by
its multi-drug resistance to antibiotics (Brooke, 2012). Moreover,
S. maltophilia strains have been found in DWDS (Guyot et al., 2013;
Vincenti et al., 2014) and shown to be resistant to chlorine disinfection
(Gomes et al., 2016). Eight ECs, including pharmaceuticals and fra-
granceswere used in the present study. Themain classes of pharmaceu-
ticals detected in water sources (Fatta-Kassinos et al., 2011) were
tested: NSAIDs (ibuprofen, diclofenac, antipyrine), lipid regulators
(cloﬁbric acid) and antibiotics (tylosin). Carbamazepine was selected
attending its high recalcitrance and the difﬁculty to remove this com-
pound from water sources (Golan-Rozen et al., 2011). Galaxolide and
tonalide were selected as representative musk fragrances, commonly
found in water sources and already detected in human tissues (Golan-
Rozen et al., 2011; Wombacher and Hornbuckle, 2009). The main re-
sults of the present work propose that exposure to ECs for 26 d had
not a huge impact on S. maltophilia planktonic antimicrobial susceptibil-
ity. Nevertheless, the prolonged exposure to some ECs altered bioﬁlm
production and tolerance to NaOCl.2. Materials and methods
2.1. Bacteria and culture conditions
Stenotrophomonas maltophilia was used as a model microorganism
from DW (Simões et al. (2007a). Bacterial cells were grown overnight
at 25 °C and under agitation (120 rpm) in R2A broth medium: 0.5 g/L
peptone (Oxoid, Hampshire, England), 0.5 g/L glucose (CHEM-LAB,
Zedelgem, Belgium), 0.1 g/L magnesium sulfate heptahydrate (Merck,
Darmstadt, Germany), 0.3 g/L sodium pyruvate (Fluka, Steinheim,
Germany), 0.5 g/L yeast extract (Merck, Darmstadt, Germany), 0.5 g/L
casein hydrolysate (Oxoid, Hampshire, England), 0.5 g/L starch
(Sigma) and 0.4 g/L di potassium phosphate trihydrate (Applichem
Panreac, Darmstadt, Germany).
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Three nonsteroidal anti-inﬂammatory drugs (NSAIDs) (antipyrine -
ANTP - from Alfa Aesar (Karlsruhe, Germany); diclofenac sodium salt -
DCF - from Fluka Steinheim, Germany) and ibuprofen – IBP - from Alfa
Aesar, two musk fragrances (galaxolide – GAL - and tonalide - TON -
both from Sigma-Aldrich), one neuro-active drug (carbamazepine -
CBZ - from Acros Organics, New Jersey, USA), one lipid regulator
(cloﬁbric acid - CA - fromAcros Organics, New Jersey, USA) and one vet-
erinary antibiotic (tylosin - TY - from Sigma-Aldrich, Steinheim,
Germany) were selected as emerging contaminants for the experi-
ments. Stock solutions (from 800 to 1000 mg/L) were prepared in di-
methyl sulfoxide (DMSO) (Fisher Scientiﬁc, Leicestershire, UK) and
stored at −20 °C until use. The concentrations tested were prepared
from the stock solutions using synthetic tap water (STW) (EPA, 2011):
100 mg/L NaHCO3 (Fisher Scientiﬁc, Leicestershire, UK), 13 mg/L
MgSO4.7H2O (Merck, Darmstadt, Germany), 0.7 mg/L K2HPO4
(Applichem Panreac, Darmstadt, Germany), 0.3 mg/L KH2PO4 (CHEM-
LAB, Zedelgem, Belgium), 0.01 mg/L (NH4)2SO4 (Labkem, Barcelona,
Spain), 0.01 mg/L NaCl (Merck, Darmstadt, Germany), 0.001 mg/L
FeSO4.7H2O (VWR PROLABO, Leuven, Belgium), 1 mg/L NaNO3
(Labkem, Barcelona, Spain), 27 mg/L CaSO4 (Labkem, Barcelona,
Spain), 1 mg/L humic acids (Sigma-Aldrich, Steinheim, Germany)
(EPA, 2011). DMSO ﬁnal concentration in each solution was 1% (v/v).
Table 1 shows information on the ECs tested and the respective con-
centrations found in DWDS and used in the present study. The concen-
tration of each EC in combinationswas the same used for the tests using
single compounds ([DW] and 100 × [DW]).
2.3. Experimental set-up
The experimental set-up is constituted of four main steps (Fig. 1).
Firstly, S. maltophilia bioﬁlms were developed on PVC coupons for
24 h using 48wells microtiter plates (Section 2.4 – Fig. 1.A). Afterwards,
coupons with bioﬁlms were exposed to ECs for 26 d in a new 48 wells
microtiter plate (Section 2.6 – Fig. 1.B). Bioﬁlms exposed to ECs were
characterized in terms of numbers of colony forming units (CFU)
(Section 2.6). Moreover, these coupons were used to inoculate fresh
R2A broth (Section 2.6 – Fig. 1.C) to characterize the bacteria exposed
to ECs (Section 2.6 – Fig. 1.D) in terms of planktonic behaviour (deter-
mination of the minimum bactericidal concentration of NaOCl -
Section 2.6.1; susceptibility to antibiotics - Section 2.6.2), bioﬁlm pro-
ductivity (Section 2.6.3); and susceptibility to NaOCl (Section 2.6.4).
2.4. Bioﬁlm pre-establishment
S. maltophilia bioﬁlms were formed on polyvinyl chloride (PVC) for
24 h. PVC coupons (1 × 1 cm) were used as substratum for bioﬁlm for-
mation. PVC was selected as a representative pipe material from DW
networks (SDWC et al., 1982). In order to clean and sterilize PVC for fur-
ther analysis, couponswere immersed in a solution of a commercial de-
tergent (Sonasol Pril, Henkel Ibérica S.A.) in distilled water for 30 min.Table 1
Selected emergent contaminants (ECs) and respective concentration detected in DWDS. The co
in the present work.
Class of contaminants ECs
Nonsteroidal anti-inﬂammatory drugs (NSAIDs) Antipyrine
Diclofenac sodium salt
Ibuprofen
Musk fragrances Galaxolide
Tonalide
Neuro-active drug Carbamazepine
Lipid regulator Cloﬁbric acid
Veterinary antibiotic TylosinAfterwards, the coupons were rinsed in distilled water and subse-
quently immersed in ethanol at 70% for 30 min. After that, coupons
were rinsed three times with distilled sterile water and dried overnight
at 60 °C (Simões et al., 2007a). Then PVC couponswere placed in 48well
microtiter plates and exposed to ultra-violet (UV) light for 30 min be-
fore being used for bioﬁlm formation. After sterilization, 1 mL of bacte-
rial suspension in R2A broth (2 × 108 CFU/mL) was added to each well.
Microtiter plates were incubated for 24 h at 25 °C and under agitation
(120 rpm) – Fig. 1.A.
2.5. S. maltophilia bioﬁlms exposure to ECs
After 24 h, colonized PVC coupons, prepared as described in
Section 2.4, were carefully removed from the wells and placed in new
microtiter plates with STW in order to remove the weakly and non-
adherent bacteria. Then, S. maltophilia bioﬁlms were exposed to ECs
for 26 days (Fig. 1.B). For that, colonized coupons were inserted in
other microtiter plates with the ECs solutions (prepared as described
previously) using STW at environmental concentrations found in
DWDS ([DW]) and at 100 times the [DW] (100 × [DW]). ECs solutions
were renewed every 2 days, in order to ensure the continuous exposure
to a constant amount of ECs for 26 days. Before being placed in new ECs
solutions, colonized coupons were carefully washed in STW to remove
non-adherent bacteria and the ECs solution. Two controls were per-
formed: bioﬁlm in contact with STW and bioﬁlm in contact with 1%
DMSO (v/v) in STW. After 26 days of continuous exposure to ECs, the
numbers of CFU of S. maltophilia bioﬁlms were determined. The plank-
tonic behaviour of bacteria grown from bioﬁlms exposed to ECs was
also evaluated. For that, colonized coupons were used to inoculate
R2A broth (Fig. 1.C) in order to characterize bacterial susceptibility to
NaOCl and antibiotics (levoﬂoxacin and trimethoprim-
sulfamethoxazole) and its ability to form bioﬁlms.
Bacterial adaptation to ECs exposure for 26 days was performed in
duplicate with three independent assays.
2.6. Characterization of bacteria exposed to ECs
Couponswith bioﬁlms exposed to ECswere inserted in 50mL falcon
tube containing 10mL of R2A broth (Fig. 1.C). Bacterial cells were natu-
rally released from coupons to the bulk medium and were grown over-
night at 25 °C and 120 rpm for further evaluation of the effects of ECs on
S. maltophilia behaviour. These bacteria were subsequently character-
ized in terms of susceptibility to NaOCl (Section 2.6.1) and to antibiotics
(Section 2.6.2), as well as bioﬁlm formation ability (Section 2.6.3) and
bioﬁlm susceptibility to NaOCl (Section 2.6.4) – Fig. 1.D.
2.6.1. Minimum bactericidal concentrations
A pre-culture inoculated from a PVC coupon colonized with
S. maltophilia bioﬁlms exposed to ECs and grown as described previ-
ously was centrifuged (12 min, 3777g) and resuspended in STW to
achieve a concentration of 3 × 105 CFU/mL in order to mimic the num-
ber of cells present in DWDS (Prest et al., 2016). NaOCl (Acros Organics,ncentration detected in DWDS ([DWDS]) and a concentration 100 times higher was tested
Abbreviation [DWDS]
(ng/L)
References
ANTP 400 Reddersen et al. (2002)
DCF 6 Jones et al. (2005)
IBP 3 Jones et al. (2005)
GAL 2.2 Wombacher and Hornbuckle (2009)
TON 0.51 Wombacher and Hornbuckle (2009)
CBZ 24–258 Jones et al. (2005)
CA 5.3–170 Jones et al. (2005)
TY 1.7 Jones et al. (2005)
Fig. 1. Experimental set-up. A – Bioﬁlm formation for 24 h in PVC coupons (25 °C, 120 rpm). B – Bioﬁlm exposure to ECs for 26 days in STW (25 °C, 120 rpm). C – Inoculation of R2A using a
colonized coupon exposed to ECs (25 °C, 120 rpm, overnight). D – Characterization of bacteria after bioﬁlms exposure to ECs.
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40, 50, 60, 70, 80, 90, 100 and 150mg/L) in sterile distilledwater. A vol-
ume of 20 μL of each NaOCl solutionwas added to eachwell of a 96-well
microtiter plate containing 180 μL of bacterial suspension in STW. The
microtiter plate was incubated for 24 h at 25 °C and 120 rpm. Then,
180 μL of each well was discarded and 180 μL of sodium thiosulfate
(0.5% w/v) was added to quench NaOCl action (Gomes et al., 2016).
From each well, 20 μL was spread on R2A agar plates and incubated
for 48 h at 25 °C. Theminimum bactericidal concentration (MBC) corre-
sponds to the lowest concentration of NaOCl at which no growth was
found. Each condition was tested in triplicate in three independent
experiments.
2.6.2. Susceptibility to antibiotics
S. maltophilia grown as described in Section 2.6. were characterized
on its susceptibility to antibiotics by the disk diffusion susceptibility
methods according to the Clinical and Laboratory Standards Institute
(CLSI) guidelines (CLSI, 2007). Levoﬂoxacin (LEV) at 5 μg and
trimethoprim-sulfamethoxazole (TMP-SMX) at 1.25/23.75 μg were the
selected antibiotics, according to the CLSI guidelines for S maltophilia
(CLSI, 2007). A bacterial inoculum (6 × 108 CFU/mL), prepared from
coupons colonized with bioﬁlms, was exposed to ECs and spread on
Mueller-Hinton agar (MHA). MHA plates were incubated at 37 °C for
24 h before measuring the diameter of growth inhibition. Each condi-
tion was tested in duplicate with three independent experiments.
2.6.3. S. maltophilia bioﬁlm formation after exposure to ECs
Bacteria obtained from bioﬁlms exposed to ECs were characterized
in terms of bioﬁlm production. Bioﬁlms were developed according to
the modiﬁed microtiter plate test proposed by Stepanović et al.
(2000). Brieﬂy, sterile 96-wells microtiter plates were ﬁlled with 200
μL of bacterial suspension (2× 108 CFU/mL in R2A broth). Negative con-
trol wells were ﬁlled with sterile R2A. The plates were incubated for
24 h at 25 °C and agitated at 120 rpm. Bioﬁlm production was assessed
in terms of CFU and by crystal violet (Merck, Darmstadt, Germany)
staining.
2.6.3.1. CFU enumeration. After 24 h of incubation, the bulk suspension
was discarded and each well was washed with 200 μL of NaCl solution
at 8.5 g/L in order to remove the non-adhered andweakly adhered bac-
teria. Afterwards, bioﬁlms were scrapped for 1 min with the pipette tip
and resuspended two times in 250 μL of NaCl solution. The number of
CFU was assessed in R2A agar. CFU were determined 48 h after incuba-
tion at 25 °C and the results are presented in terms of log CFU/cm2.
2.6.3.2. Crystal violet staining. After 24 h of incubation the bacterial sus-
pension in themicrotiter platewasdiscarded and eachwellwaswashed
with 200 μL of sterile water in order to remove the non-adhered and
weakly adhered bacteria. Afterwards, bioﬁlms was ﬁxed with ethanol
(Fisher, Leicestershire, UK) for 15 min and stained with crystal violet
(1% v/v) for 5min. Acetic acid (33% v/v)was used to elute the crystal vi-
olet from the stained bioﬁlm. Absorbance was measured in microtiter
plate reader at 570 nm, according to Simões et al. (2007b).2.6.4. NaOCl effects on bioﬁlms formed by bacteria exposed to ECs
Bioﬁlms developed as described previously (Section 2.6.3) were
treatedwithNaOCl to evaluate bioﬁlm susceptibility to this disinfectant.
After 24 h of bioﬁlm formation, the bulk suspension was discarded and
eachwell waswashedwithNaCl solution at 8.5 g/L. Then, 180 μL of STW
and 20 μL of NaOCl solution at 10 × MIC (minimum inhibitory concen-
tration) were added to each well for 30 min at 25 °C and 120 rpm.
NaOCl was used at a ﬁnal concentration of 130mg/L as this value corre-
sponds to the minimum inhibitory concentration for S. maltophilia in
R2A broth (data not shown). Negative controls corresponded to the
use of 200 μL of STW. After 30 min exposure NaOCl was removed from
each well and the remaining biocide was neutralized with sodium thio-
sulfate at 0.50% (w/v) for 10 min (Gomes et al., 2016). NaOCl effects on
bioﬁlms were assessed by CFU enumeration and crystal violet (Merck,
Portugal) staining according to Sections 2.6.3.1 and 2.6.3.2.2.7. Statistical analysis
Data were analysed applying the one-way analysis of variance
(ANOVA) and the comparisons between and within experimental
groups were carried out using Tukey test. The software used for statisti-
cal analysis was IBM® SPSS® Statistics (Statistical Package for the
Social Sciences) version 24.0. Statistical calculationswere based on con-
ﬁdence level ≥ 95% (P b 0.05) which was considered statistically
signiﬁcant.3. Results
3.1. Effect of ECs on pre-established S. maltophilia bioﬁlms
Fig. 2 presents the log CFU/cm2 of S. maltophilia bioﬁlms grown on
PVC coupons in the presence of ECs (alone and combined) for 26 days.
The exposure to GAL slightly increased log CFU/cm2, even if no signiﬁ-
cant differences were observed from the other situations (P N 0.05). In
general, no statistical signiﬁcant differences were observed on
S. maltophilia log CFU/cm2 from the exposure to ECs at [DWDS] and at
100 × [DWDS] (P N 0.05).3.2. Effects of ECs on NaOCl action against planktonic S. maltophilia
Bacteria from the 26 days ECs exposed bioﬁlms were evaluated for
their susceptibility to NaOCl (Table 2). The MBC of NaOCl varied from
2.0 to 5.0 mg/L. The presence of 1% (v/v) of DMSO did not cause signif-
icant differences in theMBC (3.5–5.0mg/L), showing that the solvent at
the concentration used had no inﬂuence on S. maltophilia tolerance to
NaOCl (P N 0.05). CBZ at [DWDS] and the combination of CBZ and IBP
at [DWDS] caused a slight increase of MBC, however, not statistically
signiﬁcant (P N 0.05). The increase of ECs concentration to 100 ×
[DWDS] caused no signiﬁcant changes in S. maltophilia susceptibility
to NaOCl (P N 0.05).
Fig. 2. Log CFU/cm2 of S. maltophilia bioﬁlms after growing for 26 days in the presence of
the selected ECs at [DWDS] (□) and 100 × [DWDS] (■).… – bioﬁlm not exposed to ECs
(only in STW), ——— Solvent control (bioﬁlms only exposed to DMSO at 1% (v/v)). *
TON – tonalide, CA – cloﬁbric acid, CBZ – carbamazepine, DCF – diclofenac, IBP –
ibuprofen, GAL – galaxolide, ANTP – antipyrine, TY – tylosin, MIX – Mixture of all
compounds.
Table 3
Inhibition halo diameter (cm) for LEVO and TMP-SMX, after S. maltophilia exposure to ECs
for 26 days.
Inhibition halo diameter (cm)
LEVO TMP-SMX
[DWDS] 100 × [DWDS] [DWDS] 100 × [DWDS]
STW 2.90 ± 0.21 2.30 ± 0.08
DMSO 2.83 ± 0.21 2.26 ± 0.13
ECa
TON 2.81 ± 0.16 2.95 ± 0.15 2.31 ± 0.06 2.23 ± 0.09
CA 2.78 ± 0.20 2.99 ± 0.08 2.33 ± 0.07 2.38 ± 0.14
CBZ 2.73 ± 0.20 2.96 ± 0.03 2.23 ± 0.19 2.20 ± 0.20
DCF 2.77 ± 0.15 2.93 ± 0.13 2.29 ± 0.16 2.32 ± 0.19
IBP 2.74 ± 0.13 2.94 ± 0.12 2.22 ± 0.14 2.34 ± 0.16
GAL 2.77 ± 0.06 2.96 ± 0.02 2.22 ± 0.18 2.31 ± 0.13
ANTP 2.82 ± 0.09 3.09 ± 0.16 2.31 ± 0.24 2.52 ± 0.37
TY 2.84 ± 0.16 2.99 ± 0.03 2.17 ± 0.14 2.36 ± 0.11
MIX 2.84 ± 0.26 2.99 ± 0.18 2.12 ± 0.21 2.43 ± 0.16
CA + CBZ 2.84 ± 0.09 2.92 ± 0.04 2.35 ± 0.26 2.38 ± 0.13
CA + IBP 3.03 ± 0.07 3.01 ± 0.15 2.28 ± 0.23 2.43 ± 0.26
CBZ + IBP 2.90 ± 0.11 2.87 ± 0.07 2.24 ± 0.23 2.32 ± 0.15
CA + CBZ + IBP 2.85 ± 0.07 2.96 ± 0.11 2.19 ± 0.26 2.36 ± 0.20
a DMSO – dimethylsulfoxide, STW – synthetic tap water, Ton – tonalide, CA – cloﬁbric
acid, CBZ – carbamazepine, DCF – diclofenac, IBP – ibuprofen, GAL – galaxolide, ANTP – an-
tipyrine, TY – tylosin, MIX –Mixture of all compounds.
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S. maltophiliawas susceptible to the selected antibiotics (inhibition
halo ≥1.7 cm for LEVO and ≥1.6 cm for TMP-SMX) (Table 3). No signiﬁ-
cant differences in antibiotic susceptibility were observed when using
S. maltophilia grown in the absence and presence of ECs at [DWDS] or
100 × [DWDS] (P N 0.05).3.4. Effect of ECs on S. maltophilia bioﬁlm production
S. maltophilia from bioﬁlms exposed to ECs were resuspended and
used to assess its ability to produce bioﬁlms (Figs. 2 and 3). This was
performed to ascertain the inﬂuence of ECs pre-exposure in bioﬁlm pro-
duction. A slight increase in bioﬁlm production was observed when
S. maltophilia was exposed to the combinations MIX and CA + IBP
(Fig. 3). However, in general, the selected ECs (alone and combined)
at [DWDS] had no remarkable effects on the ability of S. maltophilia to
form bioﬁlms (P N 0.05). On the other hand, the exposure to ECs at
100 × [DWDS] caused some changes in bioﬁlm formation.
S. maltophilia exposed to the combination CA + CBZ + IBP at 100 ×
[DWDS] reduced bioﬁlm production (Fig. 3 and Fig. 4) (P b 0.05). TheTable 2
Minimum bactericidal concentration of NaOCl (mg/L) after S. maltophilia exposure to ECs
for 26 days.
MBC (mg/L)
[DWDS] 100 × [DWDS]
STW 2.0–5.0
DMSO 3.5–5.0
ECa
TON 3.0–6.0 3.0–4.5
CA 3.0–5.0 3.0–5.0
CBZ 4.5–6.0 2.0–6.0
DCF 3.0–5.0 3.0–5.0
IBP 3.0–5.0 3.0–5.0
GAL 3.0–5.0 3.0–5.0
ANTP 2.5–6.0 3.0–6.0
TY 2.0–5.0 3.5–4.0
MIX 4.0–5.0 3.5–5.0
CA + CBZ 4.0–5.5 4.5–5.0
CA + IBP 4.0–5.5 2.5–5.5
CBZ + IBP 4.0–6.5 2.5–5.5
CA + CBZ + IBP 4.0–5.0 3.5–4.0
a DMSO – dimethylsulfoxide, STW – synthetic tap water, Ton – tonalide, CA – cloﬁbric
acid, CBZ – carbamazepine, DCF – diclofenac, IBP – ibuprofen, GAL – galaxolide, ANTP – an-
tipyrine, TY – tylosin, MIX –mixture of all compounds.exposure to DCF, IBP and TY at 100× [DWDS] increased bioﬁlm produc-
tion, particularly in terms of total biomass (Fig. 4 – P b 0.05). These dif-
ferences were not observed in terms of bioﬁlm CFU (Fig. 3 - P N 0.05).
Only a modest increase in bioﬁlm CFU was observed from the exposure
to CA and MIX at 100 × [DWDS] (P N 0.05).
3.5. Effect of ECs on the susceptibility of S. maltophilia bioﬁlms to NaOCl
The susceptibility of S. maltophilia bioﬁlms to NaOCl was evaluated
in terms of CFU (Fig. 3) and biomass removal (Fig. 5). The treatment
with NaOCl at 130mg/L for 30min was not enough to completely inac-
tivate or remove bioﬁlms. NaOCl had no effects on bioﬁlm CFU reduc-
tion, regardless the ECs and the concentration under which the
bioﬁlms were grown (Fig. 3). In terms of removal, the bioﬁlms formed
by bacteria grown in the presence of CA + CBZ at [DWDS] and to CA
+ CBZ + IBP at 100 × [DWDS] were more resistant to removal by
NaOCl (P b 0.05). The exposure to TY and MIX at [DWDS] and at 100 ×
[DWDS] slightly decreased bioﬁlm removal, althoughwithout statistical
signiﬁcance (P N 0.05).
4. Discussion
Recent studies have demonstrated the presence of ECs in DWDS
highlighting their potential public health risks. In fact, there is the po-
tential toxicological risk from the intake of chemically contaminated
water (Schriks et al., 2010). However, DWDS are highly colonized by
microorganisms. This is particularly relevant when looking to the sur-
face materials of DWDS where the microorganisms can account for
95% of the cells present in the system (Flemming et al., 2002). These
cells are inevitably exposed to trace concentrations of ECs. Nevertheless,
to our knowledge no studies are available on the effects of ECs on the be-
haviour of DW bacteria and on their susceptibility to disinfection. The
study of ECs mainly focuses human health and aquatic life, including
the study of ﬂuvial bioﬁlms (Brodin et al., 2014; Lei et al., 2015; Luis
et al., 2016). In this study, a S. maltophilia strain isolated from a DWDS
(Simões et al., 2007a) was selected to assess the role of ECs on bioﬁlm
formation and antimicrobial susceptibility. S. maltophilia is considered
an emerging pathogen and strains of this species are encountered in
DW (Brooke, 2012; Guyot et al., 2013; Vincenti et al., 2014).
This study demonstrates that ECs (alone and combined) at the con-
centrations used had no antimicrobial effects on S. maltophilia bioﬁlms.
Also, they had no noticeable action in stimulating bioﬁlm development
Fig. 3. Log CFU/cm2 of 24 h S. maltophilia bioﬁlms formed after the previous exposure to ECs at [DWDS] and 100 × [DWDS] for 26 d to formbioﬁlms and treatedwith NaOCl at 130mg/L for
30min.□ – 0mg/L of NaOCl (bioﬁlm formation);■ – 130mg/L of NaOCl (bioﬁlm inactivation);…– bioﬁlmnot exposed to ECs (only in STW),——— Solvent control, bioﬁlms only exposed
to DMSO. * Ton – tonalide, CA – cloﬁbric acid, CBZ – carbamazepine, DCF – diclofenac, IBP – ibuprofen, GAL – galaxolide, ANTP – antipyrine, TY – tylosin, MIX –Mixture of all compounds.
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not affected after 26 d exposure to ECs). Nevertheless, the presence of
ECs at higher concentrations in rivers was found to change the compo-
sition of bioﬁlm communities, depending on the ECs present in the en-
vironment (Bonnineau et al., 2010; Corcoll et al., 2015; Proia et al., 2011;
Proia et al., 2013; Shaw et al., 2015). For example, Bonnineau et al.
(2010) exposed ﬂuvial bioﬁlms to β-blockers at different concentra-
tions (0.9 μg/L to 9000 μg/L for propranolol and metoprolol, 0.9 μg/L to
900,000 μg/L for atenolol) and described that higher concentrations of
metoprolol were toxic for bacteria and propranolol was responsible
for the inhibition of algal photosynthesis. On the other hand, Proia
et al. (2013) studied the effect of polluted and highly polluted water
on ﬂuvial bioﬁlms and concluded that the presence of high concentra-
tions of ibuprofen and paracetamol in river waters may be responsible
for a decrease in algal photosynthetic capacity. Other studies reported
bacterial death on ﬂuvial bioﬁlms caused mainly by the presence ofFig. 4.Bioﬁlm formation for 24 h after S. maltophilia exposure to ECs for 26 days in terms of total
[DWDS];… - bioﬁlm not exposed to ECs (only in STW),——— Solvent control, bioﬁlms only exp
IBP – ibuprofen, GAL– galaxolide, ANTP – antipyrine, TY – tylosin,MIX –Mixture of all compoun
to the web version of this article.)antimicrobial contaminants, particularly antibiotics (erythromycin, tri-
methoprim and clindamycin) (Waiser et al., 2016) and triclosan (Proia
et al., 2011; Ricart et al., 2010; Shaw et al., 2015; Waiser et al., 2016).
Also, Osorio et al. (2014) observed a decrease of bacterial viability
when bioﬁlms were translocated from a less to a more polluted site of
the river. Therefore, bioﬁlms can be an important way to evaluate the
impact of ECs onwater systems (Aubertheau et al., 2017). Nevertheless,
it is important to mention that ﬂuvial bioﬁlms are signiﬁcantly different
fromDWDS bioﬁlms, as they are composed by algae, bacteria, protozoa,
cyanobacteria and fungi and are not formed in the presence of chronic
residual concentrations of disinfectant (Corcoll et al., 2015). These dif-
ferences limit any accurate comparison between the results obtained
in the present study and the available literature.
The use of chlorine is the most commonly used strategy for DW dis-
infection. However, the existence of DW bacteria resistant to chlorine is
a public health concern and different works already reported thebiomass assessed by crystal violet staining (absorbance at 570 nm).□ – [DWDS];■ – 100×
osed to DMSO. * Ton – tonalide, CA – cloﬁbric acid, CBZ – carbamazepine, DCF – diclofenac,
ds. (For interpretation of the references to colour in thisﬁgure legend, the reader is referred
Fig. 5. Bioﬁlm removal after treatment with NaOCl at 130mg/L for 30 min.□ – [DWDS];■ – 100 × [DWDS];…– bioﬁlm not exposed to ECs (only in STW),——— Solvent control, bioﬁlms
only exposed to DMSO. * TON – tonalide, CA – cloﬁbric acid, CBZ – carbamazepine, DCF – diclofenac, IBP – ibuprofen, GAL – galaxolide, ANTP – antipyrine, TY – tylosin, MIX –Mixture of all
compounds.
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et al., 2013). Sun et al. (2013) identiﬁed and characterized a new chlo-
rine resistant bacterium isolated from a model DWDS (Sphingomonas
TS001), which survived to 4 mg/L of chlorine for 240 min. Khan et al.
(2016) concluded that the presence of chlorine-resistant bacteria sur-
viving in DWDS may carry additional risk of antibiotic resistance. To
our knowledge, no previous work was done regarding the effects of
ECs on bacterial susceptibility to chlorine. This study shows that CBZ
slightly increased planktonic S. maltophilia tolerance to chlorine. It is
possible that the presence of ECs in chlorinated DWDSmay reduce chlo-
rine levels due to ECs degradation by chlorination (Snyder et al., 2003;
Weng et al., 2014; Westerhoff et al., 2005). Therefore, in this work the
mixture of ECs with chlorinewas avoided in order to understand the in-
dividual effects of ECs on bacterial susceptibility to chlorine.
DWDS are a recognized pool of antibiotic resistant bacteria and their
genes (Bergeron et al., 2015; Schwartz et al., 2003; Xi et al., 2009; Xu
et al., 2016). In this study, LEVO and TMP-SMXwere tested on their an-
timicrobial action against cells of S. maltophilia obtained from bioﬁlms
grown in the presence for ECs for 26 d. The development of antibiotic re-
sistance by bacteria found in aquatic environments exposed to trace
levels of antibiotics has been already reported (Baquero et al., 2008;
Hong et al., 2013; Martinez, 2009). More recently, Subirats et al.
(2017, 2018) demonstrated thatwater sources pollutedwith ECs are re-
sponsible for bacterial antibiotic resistance in streambioﬁlms. However,
reduced information is available about the possible effects of non-
antibiotic compounds on bacterial tolerance to antibiotics. In the pres-
ent study, trace levels of TY (a veterinary antibiotic) did not cause signif-
icant changes on S. maltophilia tolerance to LEVO and to TMP-SMX. It is
important to highlight that studies correlating the exposure to antibi-
otics in the environment with the spread of resistance used antibiotics
at least at 1 μg/L (Bengtsson-Palme et al., 2016; Henderson-Begg et al.,
2006; Jutkina et al., 2016; López and Blázquez, 2009; Lundstrom et al.,
2016), which is a concentration signiﬁcantly higher than these tested
in the present work (1.7 to 10.7 ng/L for TY - the only antimicrobial EC
tested). Also, the short-term exposure of S. maltophilia to non-
antibiotic compounds did not alter signiﬁcantly bacterial tolerance to
LEVO and TMP-SMX.
The exposure to ECs at [DWDS] did not alter the ability of
S. maltophilia to form bioﬁlms in a signiﬁcant manner. Nevertheless,
the exposure to TY, MIX and CA + CBZ at [DWDS] led to the formation
of bioﬁlms more tolerant to NaOCl. The exposure to higher concentra-
tions of ECs (DCF, TY and CA+CBZ+ IBP at 100× [DWDS]) altered bio-
ﬁlm formation. After being exposed to CA+CBZ+ IBP at 100× [DWDS]S. maltophilia formed lower amounts of bioﬁlm. Moreover, this bioﬁlm
was more tolerant to NaOCl. On the other hand, the exposure to DCF
and TY at 100 × [DWDS] increased S. maltophilia bioﬁlm production.
The bioﬁlms formed after exposure to TY and CA + CBZ and MIX were
also more tolerant to NaOCl. It is known that some compounds, even
when not speciﬁc to target bacteria may change bacterial behaviour,
as happened in the current study. In fact, previous works reported
that NSAIDs such as DCF and IBP are responsible for changes in the gut
microbiome (Guslandi, 2012; Rogers and Aronoff, 2016). Cycoń et al.
(2016) also found that NSAIDs are responsible for biochemical and mi-
crobiological changes in soil.
The results was shown that the simultaneous presence of different
ECs (CA + CBZ, CA + IBP, CA + CBZ + IBP) have changed planktonic
and sessile bacterial behaviour. CA was the single compound present
in all the combinations that altered bacterial behaviour, increasing the
ability of S. maltophilia to form bioﬁlms and/or increasing bioﬁlm toler-
ance to NaOCl. DeLorenzo and Fleming (2008) also found that the com-
bination of CA with simvastatin was more toxic for phytoplankton than
the exposure to these compounds individually. In another study,
Balague et al. (2004) found that CA prevented the assemblage of the
ﬁmbria subunits or/and cause genetic control inhibition of ﬁmbriae ex-
pression in Escherichia coli. Combinations of ECs were also found to
cause toxic effects in non-target aquatic organisms (Cleuvers, 2003;
Schnell et al., 2009).
5. Conclusions
The presence of ECs in DWDS can constitute a cause of concern for
consumers and DW companies regarding their effects on the behaviour
of the DW-colonizingmicrobiota. In this study, it was found no clear ev-
idence of the exposure to ECs and changes in planktonic S. maltophilia
susceptibility to NaOCl and antibiotics. Nevertheless, some ECs (DCF,
IBP, TY and CA + CBZ + IBP at 100 × [DWDS]) were responsible for
changes in S. maltophilia ability to form bioﬁlms and on their tolerance
to NaOCl (CA + CBZ at [DWDS] and CA + CBZ + IBP at 100 ×
[DWDS]). Therefore, the simultaneous presence of different com-
pounds, even if at trace concentrations, altered S. maltophilia bioﬁlm be-
haviour and can potentially hinder the disinfection of bioﬁlms inDWDS.
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